Eton Pharmaceuticals (ETON) Receivables - Net: 2019-2025
Historic Receivables - Net for Eton Pharmaceuticals (ETON) over the last 5 years, with Sep 2025 value amounting to $13.1 million.
- Eton Pharmaceuticals' Receivables - Net rose 133.98% to $13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year increase of 133.98%. This contributed to the annual value of $5.4 million for FY2024, which is 57.17% up from last year.
- Eton Pharmaceuticals' Receivables - Net amounted to $13.1 million in Q3 2025, which was down 9.49% from $14.5 million recorded in Q2 2025.
- Eton Pharmaceuticals' 5-year Receivables - Net high stood at $14.5 million for Q2 2025, and its period low was $300,000 during Q1 2021.
- Over the past 3 years, Eton Pharmaceuticals' median Receivables - Net value was $4.3 million (recorded in 2025), while the average stood at $5.9 million.
- As far as peak fluctuations go, Eton Pharmaceuticals' Receivables - Net skyrocketed by 10,316.67% in 2021, and later tumbled by 62.96% in 2022.
- Eton Pharmaceuticals' Receivables - Net (Quarterly) stood at $5.0 million in 2021, then tumbled by 62.96% to $1.9 million in 2022, then soared by 84.18% to $3.4 million in 2023, then soared by 57.17% to $5.4 million in 2024, then skyrocketed by 133.98% to $13.1 million in 2025.
- Its Receivables - Net was $13.1 million in Q3 2025, compared to $14.5 million in Q2 2025 and $4.3 million in Q1 2025.